Corneal Edema Clinical Trial
Official title:
A Randomized, Open-Label, Parallel-Group Study to Evaluate the Safety and Efficacy of Two Dosing Regimens of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy
Two different dosing regimens (QD and BID) of netarsudil will be studied to evaluate their efficacy in reducing or resolving corneal edema in subjects with FCD.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05139771 -
EndoArt® Implantation in Subjects With Chronic Corneal Edema
|
N/A | |
Enrolling by invitation |
NCT05956535 -
Air Optix® Night and Day® Aqua Therapeutic Wear
|
||
Completed |
NCT02332109 -
ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy
|
N/A | |
Active, not recruiting |
NCT06041256 -
A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)
|
Phase 1/Phase 2 | |
Completed |
NCT04521140 -
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery
|
Phase 4 | |
Completed |
NCT05136443 -
Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection
|
Phase 4 | |
Completed |
NCT01998568 -
The Intraocular Pressure Measured by Different Tonometers in Corneal Edema
|
N/A | |
Recruiting |
NCT04191629 -
Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema
|
Phase 1 | |
Completed |
NCT04975971 -
A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery
|
||
Completed |
NCT05309135 -
A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial Dysfunction
|
Phase 1 | |
Completed |
NCT01853696 -
Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty
|
Phase 4 | |
Completed |
NCT01244334 -
Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.
|
Phase 4 | |
Completed |
NCT05891106 -
AONDA Therapeutic Indication Study I
|
||
Active, not recruiting |
NCT04894110 -
Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema
|
Phase 1 | |
Completed |
NCT01387620 -
Comparison of DisCoVisc and Hydroxypropylmethylcellulose 2%
|
Phase 4 | |
Completed |
NCT00346138 -
A Comparison Between Full Thickness and Partial Thickness Corneal Transplantation for Corneal Edema
|
N/A | |
Completed |
NCT05271058 -
Effect of Intracameral Steroids During Phacoemulsification on the Cornea
|
Phase 3 | |
Recruiting |
NCT05626478 -
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
|
Phase 4 | |
Completed |
NCT01890252 -
Hyper-CLâ„¢ Lens (Hyper Osmotic Contact Lens) In Subjects Suffering From Corneal Edema
|
N/A | |
Not yet recruiting |
NCT00800423 -
Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema
|
Phase 3 |